Related Experiment Video

Updated: Jun 20, 2026

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer
08:34

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer

Published on: April 13, 2015

CDKs as therapeutic targets for the human genetic disease tuberous sclerosis?

M Rosner1, H Dolznig, C Fuchs

  • 1Medical University of Vienna, Vienna, Austria.

European Journal of Clinical Investigation
|September 12, 2009
PubMed

Insights

Tuberin, a protein linked to tuberous sclerosis, influences cell growth by interacting with mTOR and p27. This research suggests p27 and CDKs as potential therapeutic targets for hamartoma treatment.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Genetics

Background:

  • Tuberin, encoded by the tuberous sclerosis gene 2, is a key regulator of the mammalian target of rapamycin (mTOR) pathway.
  • Tuberin interacts with the cyclin-dependent kinase (CDK) inhibitor p27(Kip1) (p27), influencing its stability and cellular localization through mTOR-dependent and -independent pathways.

Purpose of the Study:

  • To investigate the role of tuberin in regulating p27 localization and stability.
  • To explore the interplay between tuberin, mTOR, and the serum- and glucocorticoid-inducible kinase (SGK1) in p27 phosphorylation and localization.
  • To evaluate p27 and CDKs as potential therapeutic targets for tuberous sclerosis-associated hamartomas.

Main Methods:

  • The study likely involved molecular biology techniques to analyze protein interactions and cellular localization.
  • Investigated the effects of tuberin on p27 stability and localization.
  • Examined the role of mTOR and SGK1 in mediating tuberin's effects on p27.

Main Results:

  • Tuberin regulates p27 stability and localization through both mTOR-dependent and -independent mechanisms.
  • Tuberin influences p27 localization by modulating mTOR's activation of SGK1, which phosphorylates p27.
  • These findings highlight a complex regulatory network involving tuberin, mTOR, SGK1, and p27.

Conclusions:

  • The findings support the consideration of p27 and CDKs as therapeutic targets for hamartomas in tuberous sclerosis.
  • Understanding the tuberin-mTOR-p27 axis provides new insights into hamartoma development.
  • This research suggests that targeting p27 and CDKs, in addition to mTOR inhibitors, may offer novel therapeutic strategies for tuberous sclerosis.

More Related Videos

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus (KSHV)07:02

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus (KSHV)

Published on: September 14, 2010

Related Concept Videos

M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...